#cohort_name	a_genotype	b_genotype	nsig	n_tests_performed	hpo_item	with_geno_a	with_geno_b	pval	adj_pval
ATP13A2	OMIM:606693	OMIM:617225	2	29	Bradykinesia [HP:0002067]	30/32 (94%)	4/10 (40%)	9.15e-04	0.013
ATP13A2	OMIM:606693	OMIM:617225	2	29	Parkinsonism [HP:0001300]	28/28 (100%)	3/11 (27%)	2.68e-06	7.78e-05
BRD4	NIPBL	BRD4	1	34	Intrauterine growth retardation [HP:0001511]	37/45 (82%)	2/9 (22%)	9.45e-04	0.032
EHMT1	N Term Frameshift	other	1	60	Attention deficit hyperactivity disorder [HP:0007018]	4/8 (50%)	3/96 (3%)	4.83e-04	0.029
FBN1	TB domain	cbEGF	7	20	Disproportionate tall stature [HP:0001519]	2/40 (5%)	12/43 (28%)	0.007	0.029
FBN1	TB domain	cbEGF	7	20	Ectopia lentis [HP:0001083]	9/18 (50%)	48/59 (81%)	0.013	0.038
FBN1	TB domain	cbEGF	7	20	Mitral valve prolapse [HP:0001634]	1/28 (4%)	13/47 (28%)	0.012	0.038
FBN1	TB domain	cbEGF	7	20	Proportionate short stature [HP:0003508]	20/36 (56%)	0/24 (0%)	2.35e-06	2.35e-05
FBN1	TB domain	cbEGF	7	20	Severe short stature [HP:0003510]	15/36 (42%)	0/24 (0%)	1.36e-04	9.04e-04
FBN1	TB domain	cbEGF	7	20	Short stature [HP:0004322]	23/39 (59%)	0/24 (0%)	4.39e-07	8.79e-06
FBN1	TB domain	cbEGF	7	20	Tall stature [HP:0000098]	7/38 (18%)	21/40 (52%)	0.002	0.011
FBN1	exon 37	other	3	21	Arachnodactyly [HP:0001166]	0/8 (0%)	52/95 (55%)	0.003	0.019
FBN1	exon 37	other	3	21	Ectopia lentis [HP:0001083]	1/9 (11%)	78/100 (78%)	1.12e-04	0.001
FBN1	exon 37	other	3	21	Stiff skin [HP:0030053]	8/9 (89%)	0/50 (0%)	4.06e-09	8.52e-08
FBN1	fs last two	other	1	17	Hyperextensibility of the finger joints [HP:0001187]	2/2 (100%)	1/90 (1%)	7.17e-04	0.012
FBN1	missense	other	3	27	Arachnodactyly [HP:0001166]	34/81 (42%)	18/22 (82%)	0.001	0.026
FBN1	missense	other	3	27	Hyperextensibility of the finger joints [HP:0001187]	0/78 (0%)	3/14 (21%)	0.003	0.026
FBN1	missense	other	3	27	Thoracic aortic aneurysm [HP:0012727]	25/64 (39%)	12/14 (86%)	0.002	0.026
FBXL4	missense/other OR other/other	missense/missense	1	55	Feeding difficulties [HP:0011968]	23/24 (96%)	13/27 (48%)	1.73e-04	0.010
FGD1	Missense	Other	1	52	Broad foot [HP:0001769]	1/7 (14%)	14/15 (93%)	6.22e-04	0.032
GLI3	Fs in mid region or splice	other	5	24	Anal atresia [HP:0002023]	7/25 (28%)	3/57 (5%)	0.007	0.036
GLI3	Fs in mid region or splice	other	5	24	Nail dysplasia [HP:0002164]	7/20 (35%)	2/54 (4%)	0.001	0.009
GLI3	Fs in mid region or splice	other	5	24	Preaxial foot polydactyly [HP:0001841]	5/25 (20%)	32/57 (56%)	0.003	0.021
GLI3	Fs in mid region or splice	other	5	24	Y-shaped metacarpals [HP:0006042]	11/23 (48%)	4/56 (7%)	9.94e-05	0.001
GLI3	Fs in mid region or splice	other	5	24	Y-shaped metatarsals [HP:0010567]	11/19 (58%)	4/50 (8%)	3.25e-05	7.80e-04
GLI3	Truncating variants in Exon 15	other	5	24	Anal atresia [HP:0002023]	8/28 (29%)	2/54 (4%)	0.002	0.017
GLI3	Truncating variants in Exon 15	other	5	24	Macrocephaly [HP:0000256]	13/16 (81%)	15/42 (36%)	0.003	0.017
GLI3	Truncating variants in Exon 15	other	5	24	Postaxial foot polydactyly [HP:0001830]	9/20 (45%)	2/35 (6%)	8.91e-04	0.011
GLI3	Truncating variants in Exon 15	other	5	24	Preaxial foot polydactyly [HP:0001841]	7/28 (25%)	30/54 (56%)	0.010	0.050
GLI3	Truncating variants in Exon 15	other	5	24	Syndactyly [HP:0001159]	5/17 (29%)	33/38 (87%)	4.82e-05	0.001
GLI3	Variants in C-terminal third	other	4	24	Macrocephaly [HP:0000256]	13/15 (87%)	15/43 (35%)	7.31e-04	0.004
GLI3	Variants in C-terminal third	other	4	24	Postaxial foot polydactyly [HP:0001830]	9/16 (56%)	2/39 (5%)	7.35e-05	0.002
GLI3	Variants in C-terminal third	other	4	24	Postaxial hand polydactyly [HP:0001162]	15/16 (94%)	21/49 (43%)	3.40e-04	0.003
GLI3	Variants in C-terminal third	other	4	24	Syndactyly [HP:0001159]	5/16 (31%)	33/39 (85%)	2.25e-04	0.003
IKZF1	p.Asn159Ser	Other variant	2	29	Recurrent pneumonia [HP:0006532]	7/9 (78%)	7/39 (18%)	0.001	0.035
IKZF1	p.Asn159Ser	Other variant	2	29	T-cell acute lymphoblastic leukemias [HP:0006727]	3/13 (23%)	0/69 (0%)	0.003	0.047
ITPR1	GS Hotspot	other	5	26	Aniridia [HP:0000526]	14/20 (70%)	6/48 (12%)	6.13e-06	1.59e-04
ITPR1	GS Hotspot	other	5	26	Delayed ability to sit [HP:0025336]	13/13 (100%)	40/68 (59%)	0.003	0.030
ITPR1	GS Hotspot	other	5	26	Delayed ability to walk [HP:0031936]	14/14 (100%)	40/67 (60%)	0.003	0.030
ITPR1	GS Hotspot	other	5	26	Delayed gross motor development [HP:0002194]	18/18 (100%)	57/83 (69%)	0.005	0.032
ITPR1	GS Hotspot	other	5	26	Motor delay [HP:0001270]	19/19 (100%)	68/94 (72%)	0.006	0.032
ITPR1	IP3 binding	other	8	26	Aniridia [HP:0000526]	0/14 (0%)	20/54 (37%)	0.007	0.024
ITPR1	IP3 binding	other	8	26	Delayed ability to sit [HP:0025336]	11/11 (100%)	42/70 (60%)	0.013	0.043
ITPR1	IP3 binding	other	8	26	Delayed ability to walk [HP:0031936]	13/13 (100%)	41/68 (60%)	0.004	0.019
ITPR1	IP3 binding	other	8	26	Delayed gross motor development [HP:0002194]	18/18 (100%)	57/83 (69%)	0.005	0.024
ITPR1	IP3 binding	other	8	26	Delayed speech and language development [HP:0000750]	13/13 (100%)	37/63 (59%)	0.003	0.019
ITPR1	IP3 binding	other	8	26	Motor delay [HP:0001270]	24/24 (100%)	63/89 (71%)	0.002	0.019
ITPR1	IP3 binding	other	8	26	Neurodevelopmental delay [HP:0012758]	29/29 (100%)	70/90 (78%)	0.003	0.019
ITPR1	IP3 binding	other	8	26	Nystagmus [HP:0000639]	25/26 (96%)	53/78 (68%)	0.003	0.019
ITPR1	SV Deletion	other	8	22	Delayed ability to sit [HP:0025336]	0/19 (0%)	53/62 (85%)	4.56e-12	1.67e-11
ITPR1	SV Deletion	other	8	22	Delayed ability to walk [HP:0031936]	0/19 (0%)	54/62 (87%)	1.47e-12	7.57e-12
ITPR1	SV Deletion	other	8	22	Delayed gross motor development [HP:0002194]	0/19 (0%)	75/82 (91%)	4.04e-15	2.96e-14
ITPR1	SV Deletion	other	8	22	Delayed speech and language development [HP:0000750]	0/19 (0%)	50/57 (88%)	1.72e-12	7.57e-12
ITPR1	SV Deletion	other	8	22	Global developmental delay [HP:0001263]	0/19 (0%)	48/57 (84%)	1.81e-11	5.68e-11
ITPR1	SV Deletion	other	8	22	Motor delay [HP:0001270]	0/19 (0%)	87/94 (93%)	3.90e-16	4.29e-15
ITPR1	SV Deletion	other	8	22	Neurodevelopmental delay [HP:0012758]	0/19 (0%)	99/100 (99%)	4.07e-21	8.96e-20
ITPR1	SV Deletion	other	8	22	Nystagmus [HP:0000639]	17/17 (100%)	61/87 (70%)	0.006	0.016
KCNH5	Arg327His	Arg333His	1	26	Epileptic encephalopathy [HP:0200134]	15/15 (100%)	0/3 (0%)	0.001	0.032
KDM6A	FEMALE	MALE	1	4	Intellectual disability, severe [HP:0010864]	7/25 (28%)	14/18 (78%)	0.002	0.008
KDM6A	p.Asn891ValfsTer27	Other	1	29	Pulmonic stenosis [HP:0001642]	2/2 (100%)	0/59 (0%)	5.46e-04	0.016
Kabuki	OMIM:147920	OMIM:300867	2	34	Feeding difficulties [HP:0011968]	8/25 (32%)	55/63 (87%)	7.41e-07	2.52e-05
Kabuki	OMIM:147920	OMIM:300867	2	34	Motor delay [HP:0001270]	4/10 (40%)	58/61 (95%)	1.04e-04	0.002
LDS 1 and 3	OMIM:609192	OMIM:613795	4	24	Aortic aneurysm [HP:0004942]	11/11 (100%)	26/48 (54%)	0.004	0.027
LDS 1 and 3	OMIM:609192	OMIM:613795	4	24	Hypertelorism [HP:0000316]	15/19 (79%)	13/35 (37%)	0.004	0.027
LDS 1 and 3	OMIM:609192	OMIM:613795	4	24	Osteoarthritis [HP:0002758]	0/11 (0%)	26/38 (68%)	4.64e-05	0.001
LDS 1 and 3	OMIM:609192	OMIM:613795	4	24	Scoliosis [HP:0002650]	18/21 (86%)	20/43 (47%)	0.003	0.027
LDS 3 and 6	OMIM:613795	OMIM:619656	1	25	Thoracic aortic aneurysm [HP:0012727]	0/22 (0%)	10/16 (62%)	1.69e-05	4.23e-04
LMNA	Gly608=	Other	8	12	Distal muscle weakness [HP:0002460]	0/15 (0%)	36/97 (37%)	0.002	0.004
LMNA	Gly608=	Other	8	12	Elevated hemoglobin A1c [HP:0040217]	0/15 (0%)	79/110 (72%)	5.65e-08	6.77e-07
LMNA	Gly608=	Other	8	12	Limb muscle weakness [HP:0003690]	0/15 (0%)	38/99 (38%)	0.002	0.004
LMNA	Gly608=	Other	8	12	Lipodystrophy [HP:0009125]	15/15 (100%)	127/236 (54%)	1.87e-04	7.47e-04
LMNA	Gly608=	Other	8	12	Muscle weakness [HP:0001324]	0/15 (0%)	63/124 (51%)	6.07e-05	3.64e-04
LMNA	Gly608=	Other	8	12	Proximal muscle weakness [HP:0003701]	0/15 (0%)	53/114 (46%)	3.63e-04	0.001
LMNA	Gly608=	Other	8	12	Proximal muscle weakness in upper limbs [HP:0008997]	0/15 (0%)	35/102 (34%)	0.005	0.007
LMNA	Gly608=	Other	8	12	Upper limb muscle weakness [HP:0003484]	0/15 (0%)	35/96 (36%)	0.003	0.004
LMNA	Upstream Tail (1-383)	other	12	38	Achilles tendon contracture [HP:0001771]	17/81 (21%)	23/34 (68%)	3.37e-06	1.42e-05
LMNA	Upstream Tail (1-383)	other	12	38	Atrioventricular block [HP:0001678]	17/35 (49%)	8/117 (7%)	1.19e-07	1.50e-06
LMNA	Upstream Tail (1-383)	other	12	38	Dilated cardiomyopathy [HP:0001644]	35/69 (51%)	5/103 (5%)	2.20e-12	4.19e-11
LMNA	Upstream Tail (1-383)	other	12	38	Elbow contracture [HP:0034391]	17/79 (22%)	22/30 (73%)	9.63e-07	7.32e-06
LMNA	Upstream Tail (1-383)	other	12	38	First degree atrioventricular block [HP:0011705]	7/62 (11%)	2/116 (2%)	0.009	0.032
LMNA	Upstream Tail (1-383)	other	12	38	Foot joint contracture [HP:0008366]	17/77 (22%)	23/31 (74%)	6.70e-07	6.36e-06
LMNA	Upstream Tail (1-383)	other	12	38	Hip contracture [HP:0003273]	4/79 (5%)	9/30 (30%)	0.001	0.004
LMNA	Upstream Tail (1-383)	other	12	38	Limb joint contracture [HP:0003121]	19/79 (24%)	23/31 (74%)	2.06e-06	9.79e-06
LMNA	Upstream Tail (1-383)	other	12	38	Lipodystrophy [HP:0009125]	9/88 (10%)	133/163 (82%)	1.72e-29	6.52e-28
LMNA	Upstream Tail (1-383)	other	12	38	Lower-limb joint contracture [HP:0005750]	18/78 (23%)	23/31 (74%)	1.55e-06	8.43e-06
LMNA	Upstream Tail (1-383)	other	12	38	Second degree atrioventricular block [HP:0011706]	6/67 (9%)	1/116 (1%)	0.010	0.032
LMNA	Upstream Tail (1-383)	other	12	38	Upper-limb joint contracture [HP:0100360]	17/77 (22%)	22/30 (73%)	1.36e-06	8.43e-06
LMNA	Upstream of NLS	other	13	38	Achilles tendon contracture [HP:0001771]	21/85 (25%)	19/30 (63%)	2.66e-04	0.001
LMNA	Upstream of NLS	other	13	38	Atrioventricular block [HP:0001678]	17/36 (47%)	8/116 (7%)	2.11e-07	2.67e-06
LMNA	Upstream of NLS	other	13	38	Dilated cardiomyopathy [HP:0001644]	35/70 (50%)	5/102 (5%)	4.20e-12	7.98e-11
LMNA	Upstream of NLS	other	13	38	Elbow contracture [HP:0034391]	21/83 (25%)	18/26 (69%)	1.04e-04	6.59e-04
LMNA	Upstream of NLS	other	13	38	First degree atrioventricular block [HP:0011705]	7/63 (11%)	2/115 (2%)	0.010	0.033
LMNA	Upstream of NLS	other	13	38	Foot joint contracture [HP:0008366]	21/81 (26%)	19/27 (70%)	6.20e-05	5.89e-04
LMNA	Upstream of NLS	other	13	38	Hip contracture [HP:0003273]	4/83 (5%)	9/26 (35%)	2.68e-04	0.001
LMNA	Upstream of NLS	other	13	38	Limb joint contracture [HP:0003121]	23/83 (28%)	19/27 (70%)	1.71e-04	8.14e-04
LMNA	Upstream of NLS	other	13	38	Lipodystrophy [HP:0009125]	10/93 (11%)	132/158 (84%)	1.73e-31	6.58e-30
LMNA	Upstream of NLS	other	13	38	Lower-limb joint contracture [HP:0005750]	22/82 (27%)	19/27 (70%)	8.20e-05	6.23e-04
LMNA	Upstream of NLS	other	13	38	Pancreatitis [HP:0001733]	4/7 (57%)	14/110 (13%)	0.011	0.033
LMNA	Upstream of NLS	other	13	38	Second degree atrioventricular block [HP:0011706]	6/68 (9%)	1/115 (1%)	0.011	0.033
LMNA	Upstream of NLS	other	13	38	Upper-limb joint contracture [HP:0100360]	21/81 (26%)	18/26 (69%)	1.23e-04	6.66e-04
LMNA	missense	other	2	38	Elevated hemoglobin A1c [HP:0040217]	73/101 (72%)	6/24 (25%)	3.11e-05	5.90e-04
LMNA	missense	other	2	38	Loss of truncal subcutaneous adipose tissue [HP:0009002]	104/104 (100%)	4/11 (36%)	7.53e-09	2.86e-07
MPV17	Pro98Leu/Pro98Leu	other/other OR Pro98Leu/other	1	21	Peripheral axonal neuropathy [HP:0003477]	3/3 (100%)	1/22 (5%)	0.002	0.037
NBAS	missense/missense	other/other OR missense/other	1	22	Decreased circulating IgG concentration [HP:0004315]	1/12 (8%)	15/23 (65%)	0.002	0.035
NF1	Leu847Pro	other	6	22	Axillary freckling [HP:0000997]	50/61 (82%)	75/193 (39%)	3.55e-09	7.81e-08
NF1	Leu847Pro	other	6	22	Freckling [HP:0001480]	54/54 (100%)	223/301 (74%)	5.30e-07	5.83e-06
NF1	Leu847Pro	other	6	22	Inguinal freckling [HP:0030052]	34/60 (57%)	58/189 (31%)	3.92e-04	0.002
NF1	Leu847Pro	other	6	22	Lisch nodules [HP:0009737]	22/42 (52%)	61/242 (25%)	7.48e-04	0.003
NF1	Leu847Pro	other	6	22	Optic nerve glioma [HP:0009734]	15/33 (45%)	24/143 (17%)	8.57e-04	0.003
NF1	Leu847Pro	other	6	22	Plexiform neurofibroma [HP:0009732]	24/66 (36%)	44/329 (13%)	4.63e-05	3.39e-04
NF1	Met992del	other	5	13	Axillary freckling [HP:0000997]	0/14 (0%)	125/240 (52%)	8.57e-05	0.001
NF1	Met992del	other	5	13	Inguinal freckling [HP:0030052]	0/14 (0%)	92/235 (39%)	0.003	0.008
NF1	Met992del	other	5	13	Lipoma [HP:0012032]	5/44 (11%)	4/284 (1%)	0.003	0.008
NF1	Met992del	other	5	13	Lisch nodules [HP:0009737]	3/36 (8%)	80/248 (32%)	0.003	0.008
NF1	Met992del	other	5	13	Plexiform neurofibroma [HP:0009732]	0/44 (0%)	68/351 (19%)	2.05e-04	0.001
NF1	SV	other	1	17	Scoliosis [HP:0002650]	18/57 (32%)	38/308 (12%)	9.71e-04	0.017
NF1	p.Arg1830	other	9	22	Axillary freckling [HP:0000997]	20/79 (25%)	105/175 (60%)	3.66e-07	2.01e-06
NF1	p.Arg1830	other	9	22	Freckling [HP:0001480]	76/133 (57%)	201/222 (91%)	6.28e-13	6.91e-12
NF1	p.Arg1830	other	9	22	Inguinal freckling [HP:0030052]	8/79 (10%)	84/170 (49%)	4.86e-10	3.56e-09
NF1	p.Arg1830	other	9	22	Lisch nodules [HP:0009737]	11/91 (12%)	72/193 (37%)	6.58e-06	2.90e-05
NF1	p.Arg1830	other	9	22	Neurofibroma [HP:0001067]	5/8 (62%)	153/162 (94%)	0.012	0.030
NF1	p.Arg1830	other	9	22	Optic nerve glioma [HP:0009734]	0/39 (0%)	39/137 (28%)	1.71e-05	6.28e-05
NF1	p.Arg1830	other	9	22	Plexiform neurofibroma [HP:0009732]	0/135 (0%)	68/260 (26%)	1.71e-14	3.76e-13
NF1	p.Arg1830	other	9	22	Pulmonic stenosis [HP:0001642]	13/105 (12%)	5/162 (3%)	0.005	0.013
NF1	p.Arg1830	other	9	22	Scoliosis [HP:0002650]	8/125 (6%)	48/240 (20%)	4.02e-04	0.001
PTPN11	Missense	Other	4	4	Hypertelorism [HP:0000316]	37/41 (90%)	0/12 (0%)	6.82e-09	2.73e-08
PTPN11	Missense	Other	4	4	Intellectual disability, mild [HP:0001256]	8/23 (35%)	0/12 (0%)	0.032	0.032
PTPN11	Missense	Other	4	4	Pulmonic stenosis [HP:0001642]	18/34 (53%)	0/12 (0%)	0.001	0.002
PTPN11	Missense	Other	4	4	Webbed neck [HP:0000465]	15/20 (75%)	0/12 (0%)	2.94e-05	5.88e-05
RPGRIP1	1107del/1107del OR 1107del/other	other/other	1	16	Eye poking [HP:0001483]	16/16 (100%)	19/41 (46%)	1.30e-04	0.002
RPGRIP1	OMIM:613826	OMIM:608194	2	15	Nystagmus [HP:0000639]	64/66 (97%)	11/16 (69%)	0.003	0.020
RPGRIP1	OMIM:613826	OMIM:608194	2	15	Very low visual acuity [HP:0032122]	35/39 (90%)	4/16 (25%)	5.21e-06	7.81e-05
Robinow	OMIM:268310	OMIM:616331	4	88	Cleft palate [HP:0000175]	0/17 (0%)	5/8 (62%)	0.001	0.031
Robinow	OMIM:268310	OMIM:616331	4	88	Hearing impairment [HP:0000365]	3/22 (14%)	7/7 (100%)	7.69e-05	0.003
Robinow	OMIM:268310	OMIM:616331	4	88	Mesomelia [HP:0003027]	31/31 (100%)	10/15 (67%)	0.002	0.048
Robinow	OMIM:268310	OMIM:616331	4	88	Short stature [HP:0004322]	29/29 (100%)	3/11 (27%)	2.15e-06	1.89e-04
SAMD9L	Arg986Cys	Ser626Leu	3	7	Neutropenia [HP:0001875]	7/9 (78%)	0/9 (0%)	0.002	0.008
SAMD9L	Arg986Cys	Ser626Leu	3	7	Pancytopenia [HP:0001876]	4/6 (67%)	0/9 (0%)	0.011	0.026
SAMD9L	Arg986Cys	Ser626Leu	3	7	Thrombocytopenia [HP:0001873]	7/9 (78%)	0/9 (0%)	0.002	0.008
SATB2	Missense	Other	1	20	Cleft palate [HP:0000175]	11/49 (22%)	59/105 (56%)	1.11e-04	0.002
SCN2A	I repeat	Other	2	16	Intellectual disability [HP:0001249]	21/42 (50%)	157/190 (83%)	2.59e-05	4.15e-04
SCN2A	I repeat	Other	2	16	Neurodevelopmental abnormality [HP:0012759]	48/65 (74%)	198/218 (91%)	0.001	0.009
SCN2A	Missense	Other	7	16	Autism [HP:0000717]	59/146 (40%)	33/43 (77%)	2.69e-05	8.61e-05
SCN2A	Missense	Other	7	16	Focal-onset seizure [HP:0007359]	141/170 (83%)	8/33 (24%)	8.66e-11	6.93e-10
SCN2A	Missense	Other	7	16	Generalized-onset seizure [HP:0002197]	104/133 (78%)	6/31 (19%)	1.43e-09	5.72e-09
SCN2A	Missense	Other	7	16	Intellectual disability [HP:0001249]	144/198 (73%)	34/34 (100%)	9.39e-05	2.50e-04
SCN2A	Missense	Other	7	16	Motor seizure [HP:0020219]	146/175 (83%)	6/31 (19%)	4.51e-12	7.22e-11
SCN2A	Missense	Other	7	16	Neurodevelopmental abnormality [HP:0012759]	201/238 (84%)	45/45 (100%)	0.001	0.003
SCN2A	Missense	Other	7	16	Seizure [HP:0001250]	298/327 (91%)	28/53 (53%)	1.57e-10	8.38e-10
SCO2	Glu140Lys/Glu140Lys	other/other OR Glu140Lys/other	1	7	Hypertrophic cardiomyopathy [HP:0001639]	2/6 (33%)	13/13 (100%)	0.004	0.027
SETD2	Arg1740Trp	Other	7	34	Delayed ability to walk [HP:0031936]	8/8 (100%)	1/10 (10%)	4.11e-04	0.003
SETD2	Arg1740Trp	Other	7	34	Hypertelorism [HP:0000316]	11/11 (100%)	5/23 (22%)	1.53e-05	2.60e-04
SETD2	Arg1740Trp	Other	7	34	Macrocephaly [HP:0000256]	0/11 (0%)	19/28 (68%)	1.45e-04	0.002
SETD2	Arg1740Trp	Other	7	34	Scoliosis [HP:0002650]	6/6 (100%)	2/14 (14%)	7.22e-04	0.005
SETD2	Arg1740Trp	Other	7	34	Severe global developmental delay [HP:0011344]	9/9 (100%)	0/12 (0%)	3.40e-06	1.16e-04
SETD2	Arg1740Trp	Other	7	34	Ventriculomegaly [HP:0002119]	4/4 (100%)	2/17 (12%)	0.003	0.012
SETD2	Arg1740Trp	Other	7	34	Wide nasal bridge [HP:0000431]	9/9 (100%)	2/9 (22%)	0.002	0.012
SETD2	Missense	Other	1	41	Macrocephaly [HP:0000256]	4/24 (17%)	15/15 (100%)	1.54e-07	6.32e-06
SMAD3	p.Arg287Trp	Other	1	23	Osteoarthritis [HP:0002758]	19/19 (100%)	7/19 (37%)	3.72e-05	8.56e-04
SMARCB1	Structural variant	Other	6	15	Atypical teratoid/rhabdoid tumor [HP:0034401]	8/9 (89%)	2/19 (11%)	1.19e-04	5.94e-04
SMARCB1	Structural variant	Other	6	15	Embryonal neoplasm [HP:0002898]	8/8 (100%)	2/19 (11%)	2.03e-05	1.52e-04
SMARCB1	Structural variant	Other	6	15	Neoplasm by anatomical site [HP:0011793]	3/3 (100%)	3/20 (15%)	0.011	0.028
SMARCB1	Structural variant	Other	6	15	Neoplasm by histology [HP:0011792]	11/11 (100%)	4/21 (19%)	1.06e-05	1.52e-04
SMARCB1	Structural variant	Other	6	15	Neuroepithelial neoplasm [HP:0030063]	2/2 (100%)	0/17 (0%)	0.006	0.018
SMARCB1	Structural variant	Other	6	15	Rhabdoid tumor [HP:0034557]	4/4 (100%)	2/19 (11%)	0.002	0.006
SMARCC2	c.3222del	other	1	83	Intellectual disability [HP:0001249]	1/6 (17%)	49/52 (94%)	6.99e-05	0.006
SPTAN1	Arg19Trp	Other	14	25	Appendicular spasticity [HP:0034353]	21/21 (100%)	2/15 (13%)	4.54e-08	1.89e-07
SPTAN1	Arg19Trp	Other	14	25	Distal lower limb muscle weakness [HP:0009053]	8/15 (53%)	1/20 (5%)	0.002	0.004
SPTAN1	Arg19Trp	Other	14	25	Epileptic spasm [HP:0011097]	0/19 (0%)	15/20 (75%)	7.71e-07	2.75e-06
SPTAN1	Arg19Trp	Other	14	25	Infantile spasms [HP:0012469]	0/19 (0%)	15/41 (37%)	0.001	0.003
SPTAN1	Arg19Trp	Other	14	25	Intellectual disability [HP:0001249]	0/21 (0%)	27/34 (79%)	1.76e-09	1.47e-08
SPTAN1	Arg19Trp	Other	14	25	Lower limb muscle weakness [HP:0007340]	14/14 (100%)	17/30 (57%)	0.003	0.007
SPTAN1	Arg19Trp	Other	14	25	Lower limb spasticity [HP:0002061]	21/21 (100%)	0/13 (0%)	1.08e-09	1.35e-08
SPTAN1	Arg19Trp	Other	14	25	Microcephaly [HP:0000252]	0/21 (0%)	19/45 (42%)	2.45e-04	6.14e-04
SPTAN1	Arg19Trp	Other	14	25	Motor axonal neuropathy [HP:0007002]	0/16 (0%)	12/19 (63%)	6.26e-05	1.74e-04
SPTAN1	Arg19Trp	Other	14	25	Motor seizure [HP:0020219]	0/19 (0%)	20/25 (80%)	3.34e-08	1.67e-07
SPTAN1	Arg19Trp	Other	14	25	Peripheral axonal neuropathy [HP:0003477]	4/20 (20%)	12/19 (63%)	0.010	0.017
SPTAN1	Arg19Trp	Other	14	25	Seizure [HP:0001250]	2/21 (10%)	35/40 (88%)	2.36e-09	1.47e-08
SPTAN1	Arg19Trp	Other	14	25	Spastic paraplegia [HP:0001258]	21/21 (100%)	0/20 (0%)	3.72e-12	9.29e-11
SPTAN1	Arg19Trp	Other	14	25	Spasticity [HP:0001257]	21/21 (100%)	5/18 (28%)	1.05e-06	3.30e-06
SPTAN1	missense	other	14	28	Appendicular spasticity [HP:0034353]	21/22 (95%)	2/14 (14%)	8.72e-07	8.14e-06
SPTAN1	missense	other	14	28	Distal lower limb muscle weakness [HP:0009053]	9/19 (47%)	0/16 (0%)	0.001	0.004
SPTAN1	missense	other	14	28	Epileptic spasm [HP:0011097]	2/22 (9%)	13/17 (76%)	2.93e-05	1.37e-04
SPTAN1	missense	other	14	28	Infantile spasms [HP:0012469]	2/29 (7%)	13/31 (42%)	0.002	0.005
SPTAN1	missense	other	14	28	Intellectual disability [HP:0001249]	9/32 (28%)	18/23 (78%)	3.43e-04	0.001
SPTAN1	missense	other	14	28	Lower limb muscle weakness [HP:0007340]	15/16 (94%)	16/28 (57%)	0.015	0.030
SPTAN1	missense	other	14	28	Lower limb spasticity [HP:0002061]	21/22 (95%)	0/12 (0%)	2.37e-08	6.58e-07
SPTAN1	missense	other	14	28	Microcephaly [HP:0000252]	4/34 (12%)	15/32 (47%)	0.002	0.005
SPTAN1	missense	other	14	28	Motor axonal neuropathy [HP:0007002]	0/19 (0%)	12/16 (75%)	2.18e-06	1.53e-05
SPTAN1	missense	other	14	28	Motor seizure [HP:0020219]	7/27 (26%)	13/17 (76%)	0.002	0.004
SPTAN1	missense	other	14	28	Peripheral axonal neuropathy [HP:0003477]	4/23 (17%)	12/16 (75%)	6.69e-04	0.002
SPTAN1	missense	other	14	28	Seizure [HP:0001250]	13/33 (39%)	24/28 (86%)	2.48e-04	9.92e-04
SPTAN1	missense	other	14	28	Spastic paraplegia [HP:0001258]	21/25 (84%)	0/16 (0%)	4.70e-08	6.58e-07
SPTAN1	missense	other	14	28	Spasticity [HP:0001257]	22/23 (96%)	4/16 (25%)	5.22e-06	2.92e-05
SPTAN1	truncating	other	7	25	Appendicular spasticity [HP:0034353]	0/8 (0%)	23/28 (82%)	4.25e-05	2.66e-04
SPTAN1	truncating	other	7	25	Hypotonia [HP:0001252]	1/11 (9%)	15/24 (62%)	0.004	0.015
SPTAN1	truncating	other	7	25	Lower limb spasticity [HP:0002061]	0/8 (0%)	21/26 (81%)	7.09e-05	3.54e-04
SPTAN1	truncating	other	7	25	Motor axonal neuropathy [HP:0007002]	12/12 (100%)	0/23 (0%)	1.20e-09	3.00e-08
SPTAN1	truncating	other	7	25	Peripheral axonal neuropathy [HP:0003477]	12/12 (100%)	4/27 (15%)	4.65e-07	5.82e-06
SPTAN1	truncating	other	7	25	Spastic paraplegia [HP:0001258]	0/8 (0%)	21/33 (64%)	0.001	0.005
SPTAN1	truncating	other	7	25	Spasticity [HP:0001257]	0/8 (0%)	26/31 (84%)	2.09e-05	1.74e-04
SUOX	homodimerization/homodimerization OR homodimerization/Other	Other/Other	1	15	Microcephaly [HP:0000252]	0/9 (0%)	10/12 (83%)	2.21e-04	0.003
TBCK	R126*/R126*	R126*/other OR other/other	2	32	Developmental regression [HP:0002376]	9/12 (75%)	2/22 (9%)	1.83e-04	0.003
TBCK	R126*/R126*	R126*/other OR other/other	2	32	Macroglossia [HP:0000158]	11/12 (92%)	3/22 (14%)	1.34e-05	4.30e-04
TBX1	Tyr418PhefsTer42	Other	2	22	Global developmental delay [HP:0001263]	5/5 (100%)	3/20 (15%)	0.001	0.023
TBX1	Tyr418PhefsTer42	Other	2	22	Narrow nose [HP:0000460]	5/5 (100%)	0/6 (0%)	0.002	0.024
TBX5	Arg237Gln	other	2	32	Upper limb phocomelia [HP:0009813]	7/22 (32%)	3/131 (2%)	4.55e-05	7.28e-04
TBX5	Arg237Gln	other	2	32	Ventricular septal defect [HP:0001629]	0/17 (0%)	61/73 (84%)	5.55e-11	1.78e-09
TBX5	missense	other	1	32	Ventricular septal defect [HP:0001629]	31/60 (52%)	30/30 (100%)	4.63e-07	1.48e-05
TGFBR1	Gly52Arg	Other	1	7	Self-healing squamous epithelioma [HP:0034720]	7/7 (100%)	11/33 (33%)	0.002	0.012
TGFBR1	MSSE var	other	3	16	Arterial tortuosity [HP:0005116]	1/19 (5%)	8/16 (50%)	0.005	0.026
TGFBR1	MSSE var	other	3	16	Hypertelorism [HP:0000316]	0/18 (0%)	15/19 (79%)	5.01e-07	4.01e-06
TGFBR1	MSSE var	other	3	16	Self-healing squamous epithelioma [HP:0034720]	18/19 (95%)	0/21 (0%)	1.68e-10	2.68e-09
UMOD	EGF	other	1	6	Hyperuricemia [HP:0002149]	14/32 (44%)	50/57 (88%)	1.77e-05	1.06e-04
UMOD	cysteine	other	1	6	Hyperuricemia [HP:0002149]	38/41 (93%)	26/48 (54%)	4.48e-05	2.69e-04
WWOX	MAPT Interaction/MAPT Interaction OR MAPT Interaction/Other	Other/Other	1	44	Bilateral tonic-clonic seizure with focal onset [HP:0007334]	0/18 (0%)	7/9 (78%)	4.05e-05	0.002
ZFX	missense	other	1	1	Hyperparathyroidism [HP:0000843]	7/9 (78%)	0/5 (0%)	0.021	0.021
ZMYM3	R441	other	1	60	Cupped ear [HP:0000378]	7/10 (70%)	1/23 (4%)	2.02e-04	0.012
